Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C8H13N5O4.ClH |
Molecular Weight | 279.681 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.NC(=N)C1=NN(C=N1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O
InChI
InChIKey=PIGYMBULXKLTCJ-UHSSARMYSA-N
InChI=1S/C8H13N5O4.ClH/c9-6(10)7-11-2-13(12-7)8-5(16)4(15)3(1-14)17-8;/h2-5,8,14-16H,1H2,(H3,9,10);1H/t3-,4-,5-,8-;/m1./s1
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C8H13N5O4 |
Molecular Weight | 243.2199 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Taribavirin, an oral prodrug of ribavirin that was developed as nucleoside antimetabolite, which interferes with duplication of viral genetic material. Taribavirin was studied in phase III clinical trial for the treatment of chronic hepatitis C patients. However, this drug not yet approved for pharmaceutical use.
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Synthesis and antiviral activity of 1,2,4-triazole-3-thiocarboxamide and 1,2,4-triazole-3-carboxamidine ribonucleosides. | 1973 Aug |
|
Antiviral and immunomodulating inhibitors of experimentally-induced Punta Toro virus infections. | 1994 Oct |
|
New strategies for the treatment of hepatitis C virus infection and implications of resistance to new direct-acting antiviral agents. | 2010 |
|
Virologic response rates of weight-based taribavirin versus ribavirin in treatment-naive patients with genotype 1 chronic hepatitis C. | 2010 Oct |
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT00230958
viramidine (TARIBAVIRIN) 600 mg BID
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:56:54 GMT 2023
by
admin
on
Fri Dec 15 15:56:54 GMT 2023
|
Record UNII |
D22JZE246P
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C281
Created by
admin on Fri Dec 15 15:56:54 GMT 2023 , Edited by admin on Fri Dec 15 15:56:54 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID50960781
Created by
admin on Fri Dec 15 15:56:54 GMT 2023 , Edited by admin on Fri Dec 15 15:56:54 GMT 2023
|
PRIMARY | |||
|
300000045471
Created by
admin on Fri Dec 15 15:56:54 GMT 2023 , Edited by admin on Fri Dec 15 15:56:54 GMT 2023
|
PRIMARY | |||
|
C77929
Created by
admin on Fri Dec 15 15:56:54 GMT 2023 , Edited by admin on Fri Dec 15 15:56:54 GMT 2023
|
PRIMARY | |||
|
DBSALT002011
Created by
admin on Fri Dec 15 15:56:54 GMT 2023 , Edited by admin on Fri Dec 15 15:56:54 GMT 2023
|
PRIMARY | |||
|
40372-00-7
Created by
admin on Fri Dec 15 15:56:54 GMT 2023 , Edited by admin on Fri Dec 15 15:56:54 GMT 2023
|
PRIMARY | |||
|
SUB21031
Created by
admin on Fri Dec 15 15:56:54 GMT 2023 , Edited by admin on Fri Dec 15 15:56:54 GMT 2023
|
PRIMARY | |||
|
m10467
Created by
admin on Fri Dec 15 15:56:54 GMT 2023 , Edited by admin on Fri Dec 15 15:56:54 GMT 2023
|
PRIMARY | Merck Index | ||
|
451447
Created by
admin on Fri Dec 15 15:56:54 GMT 2023 , Edited by admin on Fri Dec 15 15:56:54 GMT 2023
|
PRIMARY | |||
|
D22JZE246P
Created by
admin on Fri Dec 15 15:56:54 GMT 2023 , Edited by admin on Fri Dec 15 15:56:54 GMT 2023
|
PRIMARY | |||
|
CHEMBL2111108
Created by
admin on Fri Dec 15 15:56:54 GMT 2023 , Edited by admin on Fri Dec 15 15:56:54 GMT 2023
|
PRIMARY | |||
|
QQ-41
Created by
admin on Fri Dec 15 15:56:54 GMT 2023 , Edited by admin on Fri Dec 15 15:56:54 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |